Anatol Kreitzer - 27 Oct 2025 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role
Chief Discovery Officer
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact
Issuer symbol
MPLT
Transactions as of
27 Oct 2025
Net transactions value
$0
Form type
4
Filing time
28 Oct 2025, 16:15:16 UTC
Previous filing
27 Oct 2025
Next filing
29 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kreitzer Anatol Chief Discovery Officer C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY /s/ Kristopher L. Hanson, Attorney-in-Fact 28 Oct 2025 0002021238

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MPLT Voting Common Stock Award $0 +35,953 $0.000000 35,953 27 Oct 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MPLT Employee Stock Option (right to buy) Award $0 +146,052 $0.000000 146,052 27 Oct 2025 Voting Common Stock 146,052 $17.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
F3 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.